Abstract
Background. Although the incidence of lung cancer in patients with human immunodeficiency virus (HIV) infection is increasing, the clinical course of lung cancer in HIV-infected patients is poorer than that seen in HIV-negative patients. Case. A 63-year-old man was referred to our hospital for further examination of a mass shadow detected on chest radiography. He was given a diagnosis of HIV infection during preoperative examinations. Highly active antiretroviral therapy was started at that time. By a percutaneous CT-guided fine-needle biopsy, the tumor was determined to be adenocarcinoma. The patient was clinically diagnosed with cT1bN0M0 stage IA disease and underwent right upper lobectomy with systematic lymph node dissection. The postoperative pathological diagnosis was solid adenocarcinoma (pT1bN1M0 stage IIA). His postoperative course was uneventful. Following surgery, the patient received 6 cycles of carboplatin (CBDCA) and vinorelbine (VNR) combination therapy. He is currently being followed up for 53 months after surgery. Conclusion. The result of surgical treatment and adjuvant chemotherapy following surgery in lung cancer patients with HIV infection are satisfactory as long as the performance status, organ functions and immunological status remain good.
